Low body weight and body mass index may be associated with musculoskeletal pain following imatinib discontinuation in chronic myeloid leukemia

It is difficult to predict musculoskeletal pain as a withdrawal syndrome following the discontinuation of imatinib (IM) in patients with chronic myeloid leukemia. We investigated a link between physical size and musculoskeletal pain following IM discontinuation. In total, seven out of 24 patients de...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Seiichiro Katagiri, Tetsuzo Tauchi, Keiko Ando, Seiichi Okabe, Moritaka Gotoh, Kazuma Ohyashiki
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2017-01-01
Edice:Leukemia Research Reports
Témata:
Chronic myeloid leukemia
Imatinib discontinuation
Musculoskeletal pain
Body weight
Body mass index
On-line přístup:http://www.sciencedirect.com/science/article/pii/S2213048916300577
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky